Single-center experience of extracorporeal membrane oxygenation mainly anticoagulated with nafamostat mesilate

BACKGROUND: Bleeding remains the chief concern during extracorporeal membrane oxygenation (ECMO). Recently, several studies proposed nafamostat mesilate (NM) as an alternative anticoagulant to heparin due to reduced bleeding complications and comparable thromboembolic episodes. The aim of this study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Dis
Main Authors: Han, Woosik, San Bok, Jin, Cho, Hyun Jin, Yu, Jae Hyeon, Na, Myung Hoon, Kang, Shinkwang, Kang, Min-Woong
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6687983/
https://ncbi.nlm.nih.gov/pubmed/31463115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.06.30
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados